-+ 0.00%
-+ 0.00%
-+ 0.00%

ALZAMEND NEURO REPORTS ENCOURAGING PHARMACODYNAMIC DATA FROM PHASE II CLINICAL TRIAL OF AL001 "LITHIUM IN BRAIN" STUDY IN A TRIAL CONDUCTED AT MASSACHUSETTS GENERAL HOSPITAL

Reuters·04/07/2026 12:00:32

Please log in to view news